FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vincent Praloran

Research Profile

Chemicals & Drugs

Anatomy

Physiology

Procedures

Colony Forming Units Assays

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Mohammad Hammoud; Jean-Michel Boiron; Jean Chevaleyre; Pascale Duchez; Xavier Lafarge; Vincent Praloran; Marija Vlaski; Philippe Brunet de la Grange; Zoran Ivanovic
Combination of low O(2) concentration and mesenchymal stromal cells during culture of cord blood CD34(+) cells improves the maintenance and proliferative capacity of hematopoietic stem cells.
Marie-Emmanuelle Mathieu; Virginie Mournetas; Vincent Praloran; Claire Saucourt; Nadine Thézé; Pierre Thiébaud; Xavier Gauthereau; Hélène Bœuf
LIF-dependent signaling: new pieces in the Lego.
Amélie V Guitart; Mohammad Hammoud; Persio Dello Sbarba; Zoran Ivanovic; Vincent Praloran
Slow-cycling/quiescence balance of hematopoietic stem cells is related to physiological gradient of oxygen.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vincent Praloran (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Mohammad Hammoud; Jean-Michel Boiron; Jean Chevaleyre; Pascale Duchez; Xavier Lafarge; Vincent Praloran; Marija Vlaski; Philippe Brunet de la Grange; Zoran Ivanovic
Combination of low O(2) concentration and mesenchymal stromal cells during culture of cord blood CD34(+) cells improves the maintenance and proliferative capacity of hematopoietic stem cells.
Journal of cellular physiology 2012;227(6):2750-8.
2012: Marie-Emmanuelle Mathieu; Virginie Mournetas; Vincent Praloran; Claire Saucourt; Nadine Thézé; Pierre Thiébaud; Xavier Gauthereau; Hélène Bœuf
LIF-dependent signaling: new pieces in the Lego.
Stem cell reviews 2012;8(1):1-15.
2010: Amélie V Guitart; Mohammad Hammoud; Persio Dello Sbarba; Zoran Ivanovic; Vincent Praloran
Slow-cycling/quiescence balance of hematopoietic stem cells is related to physiological gradient of oxygen.
Experimental hematology 2010;38(10):847-51.
2010: Yann Peytour; Amélie Guitart; Arnaud Villacreces; Jean Chevaleyre; Francis Lacombe; Zoran Ivanovic; Vincent Praloran
Obtaining of CD34+ cells from healthy blood donors: development of a rapid and efficient procedure using leukoreduction filters.
Transfusion 2010;50(10):2152-7.
2010: Zoran Ivanovic; Milica Kovacevic-Filipovic; Michel Jeanne; Leslie Ardilouze; Anne Bertot; Milène Szyporta; Francis Hermitte; Xavier Lafarge; Pascale Duchez; Marija Vlaski; Noel Milpied; Mirjana Pavlovic; Vincent Praloran; Jean-Michel Boiron
CD34+ cells obtained from "good mobilizers" are more activated and exhibit lower ex vivo expansion efficiency than their counterparts from "poor mobilizers".
Transfusion 2010;50(1):120-7.
2009: Michel Jeanne; Milica Kovacevic-Filipovic; Milène Szyporta; Marija Vlaski; Francis Hermitte; Xavier Lafarge; Pascale Duchez; Jean-Michel Boiron; Vincent Praloran; Zoran Ivanovic
Low-oxygen and high-carbon-dioxide atmosphere improves the conservation of hematopoietic progenitors in hypothermia.
Transfusion 2009;49(8):1738-46.
2009: Aleksandra Krstić; Marija Vlaski; Mohammad Hammoud; Jean Chevaleyre; Pascale Duchez; Gordana Jovcić; Diana Bugarski; Pavle Milenković; philippe Bourin; Jean-Michel Boiron; Vincent Praloran; Zoran Ivanović
Low O2 concentrations enhance the positive effect of IL-17 on the maintenance of erythroid progenitors during co-culture of CD34+ and mesenchymal stem cells.
European cytokine network 2009;20(1):10-6.
2007: Milica Kovacević-Filipović; Marijana Petakov; Francis Hermitte; Christelle Debeissat; Aleksandra Krstić; Gordana Jovcić; Diana Bugarski; Xavier Lafarge; Pavle Milenković; Vincent Praloran; Zoran Ivanović
Interleukin-6 (IL-6) and low O(2) concentration (1%) synergize to improve the maintenance of hematopoietic stem cells (pre-CFC).
Journal of cellular physiology 2007;212(1):68-75.
2007: Francis Belloc; François Moreau-Gaudry; Maialen Uhalde; Laurie Cazalis; Marie Jeanneteau; Francis Lacombe; Vincent Praloran; François-Xavier Mahon
Imatinib and nilotinib induce apoptosis of chronic myeloid leukemia cells through a Bim-dependant pathway modulated by cytokines.
Cancer biology & therapy 2007;6(6):912-9.
2007: Arnaud Pigneux; François-Xavier Mahon; François Moreau-Gaudry; Maialene Uhalde; Hubert de Verneuil; Francis Lacombe; Josy Reiffers; Noël Milpied; Vincent Praloran; Francis Belloc
Proteasome inhibition specifically sensitizes leukemic cells to anthracyclin-induced apoptosis through the accumulation of Bim and Bax pro-apoptotic proteins.
Cancer biology & therapy 2007;6(4):603-11.
2007: François Girodon; Eric Lippert; Pascal Mossuz; Irène Dobo; Nathalie Boiret-Dupré; Jean-François Lesesve; Sylvie Hermouet; Vincent Praloran
JAK2V617F detection and dosage of serum erythropoietin: first steps of the diagnostic work-up for patients consulting for elevated hematocrit.
Haematologica 2007;92(3):431-2.
2006: Marjorie Boissinot; Eric Lippert; François Girodon; Irène Dobo; Marc Fouassier; Claude Masliah; Vincent Praloran; Sylvie Hermouet
Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis.
Blood 2006;108(9):3223-4.
2006: Eric Lippert; Marjorie Boissinot; Robert Kralovics; François Girodon; Irène Dobo; Vincent Praloran; Nathalie Boiret-Dupré; Radek C Skoda; Sylvie Hermouet
The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera.
Blood 2006;108(6):1865-7.
2006: Joris Andrieux; Chrystèle Bilhou-Nabera; Eric Lippert; Marie-Caroline Le Bousse-Kerdiles; Brigitte Dupriez; Nathalie Grardel; Olivier Pierre-Louis; desterke christophe; Vincent Praloran; Jean-Luc Laï; Jean-Loup Demory
Expression of HMGA2 in PB leukocytes and purified CD34+ cells from controls and patients with Myelofibrosis and myeloid metaplasia.
Leukemia & lymphoma 2006;47(9):1956-9.
2006: Didier Fradelizi; Jacques Bertoglio; Vincent Praloran; Mireille Viguier
Notice of redundant publication. About the paper "Plasma levels of interleukin-18 and interleukin-12 in Plasmodium falciparum malaria" by Lucia Malaguarnera, Salvatore Pignatelli, Jacques Simporè, Mariano Malaguarnera and Salvatore Musumeci, from Department of Pediatrics, Sassari, Italy.
European cytokine network 2006;17(2):143.
2006: Jean Philippe Vial; R Tabrizi; Arnaud Pigneux; Francis Lacombe; Vincent Praloran; Francis Belloc
Remission induction chemotherapy induces in vivo caspase-dependent apoptosis in bone marrow acute myeloid leukemia blast cells and spares lymphocytes.
Cytometry. Part B, Clinical cytometry 2006;70(3):115-23.
2006: Marie Colombat; Marie-Pierre Fort; Claudine Chollet; Gérald Marit; Catherine Roche; Claude Preudhomme; Josy Reiffers; Vincent Praloran; François-Xavier Mahon
Molecular remission in chronic myeloid leukemia patients with sustained complete cytogenetic remission after imatinib mesylate treatment.
Haematologica 2006;91(2):162-8.
2006: Zoran Ivanovic; Pascale Duchez; Bernard Dazey; Francis Hermitte; Isabelle Lamrissi-Garcia; Frédéric Mazurier; Vincent Praloran; Josy Reiffers; Gérard Vezon; Jean-Michel Boiron
A clinical-scale expansion of mobilized CD 34+ hematopoietic stem and progenitor cells by use of a new serum-free medium.
Transfusion 2006;46(1):126-31.
2006: Zoran Ivanovic; Pascale Duchez; Doris A Morgan; Francis Hermitte; Xavier Lafarge; Jean Chevaleyre; Vincent Praloran; Bernard Dazey; Gérard Vezon; Jean-Michel Boiron
Whole-blood leuko-depletion filters as a source of CD 34+ progenitors potentially usable in cell therapy.
Transfusion 2006;46(1):118-25.
2006: Philippe Brunet de la Grange; Christophe Barthe; Eric Lippert; Francis Hermitte; Francis Belloc; Francis Lacombe; Zoran Ivanovic; Vincent Praloran
Oxygen concentration influences mRNA processing and expression of the cd34 gene.
Journal of cellular biochemistry 2006;97(1):135-44.
2006: Francis Hermitte; Philippe Brunet de la Grange; Francis Belloc; Vincent Praloran; Zoran Ivanovic
Very low O2 concentration (0.1%) favors G0 return of dividing CD34+ cells.
Stem cells (Dayton, Ohio) 2006;24(1):65-73.
2005: Pascal Mossuz; François Girodon; Sylvie Hermouet; Irène Dobo; Eric Lippert; Magali Donnard; Véronique Latger-Cannard; Nathalie Boiret; Vincent Praloran; Jean-Claude Lecron
Serum erythropoietin measured by chemiluminescent immunometric assay: an accurate diagnostic test for absolute erythrocytosis.
Clinical chemistry 2005;51(6):1018-21.
2005: Vanessa Desplat; Francis Belloc; Valérie Lagarde; Catherine Boyer; Junia V Melo; Josy Reiffers; Vincent Praloran; François-Xavier Mahon
Overproduction of BCR-ABL induces apoptosis in imatinib mesylate-resistant cell lines.
Cancer 2005;103(1):102-10.
2004: Vanessa Desplat; Valérie Lagarde; Francis Belloc; Claudine Chollet; Thibaut Leguay; Jean-Max Pasquet; Vincent Praloran; François-Xavier Mahon
Rapid detection of phosphotyrosine proteins by flow cytometric analysis in Bcr-Abl-positive cells.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2004;62(1):35-45.
2004: Irène Dobo; Nathalie Boiret; Eric Lippert; François Girodon; Pascal Mossuz; Magali Donnard; Lydia Campos; Danielle Pineau; Elisabeth Bascans; Vincent Praloran; Sylvie Hermouet
A standardized endogenous megakaryocytic erythroid colony assay for the diagnosis of essential thrombocythemia.
Haematologica 2004;89(10):1207-12.
2004: Pascal Mossuz; François Girodon; Magali Donnard; Véronique Latger-Cannard; Irène Dobo; Nathalie Boiret; Jean-Claude Lecron; Christine Binquet; Claire Barro; Sylvie Hermouet; Vincent Praloran
Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis.
Haematologica 2004;89(10):1194-8.
2004: Yann Le Meur; Valérie Leprivey-Lorgeot; Sandrine Mons; Mattew José; Jacques Dantal; Brigitte Lemauff; Jean-Claude Aldigier; Claude Leroux-Robert; Vincent Praloran
Serum levels of macrophage-colony stimulating factor (M-CSF): a marker of kidney allograft rejection.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(7):1862-5.
2004: Zoran Ivanovic; Francis Hermitte; Philippe Brunet de la Grange; Bernard Dazey; Francis Belloc; Francis Lacombe; Gérard Vezon; Vincent Praloran
Simultaneous maintenance of human cord blood SCID-repopulating cells and expansion of committed progenitors at low O2 concentration (3%).
Stem cells (Dayton, Ohio) 2004;22(5):716-24.
2004: Irène Dobo; Magali Donnard; François Girodon; Pascal Mossuz; Nathalie Boiret; Rachida Boukhari; Annie Allégraud; Elisabeth Bascans; Lydia Campos; Danielle Pineau; Pascal Turlure; Vincent Praloran; Sylvie Hermouet
Standardization and comparison of endogenous erythroid colony assays performed with bone marrow or blood progenitors for the diagnosis of polycythemia vera.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(2):161-7.
2003: Pierre Champelovier; Annick Simon; Catherine Garrel; Geraldine Levacher; Vincent Praloran; Daniel Seigneurin
Is interferon gamma one key of metastatic potential increase in human bladder carcinoma?
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(12):4562-9.
2003: Chrystèle Bilhou-Nabéra; Christophe Brigaudeau; Denis Clay; Joris Andrieux; Jean-Luc Lai; Danièle Brouty-Boyé; Christine Vignon; Marie-Josée Gharbi; Marie-Caroline Le Bousse-Kerdilès; Vincent Praloran
Does cytogenetic mosaicism in CD34+CD38low cells reflect the persistence of normal primitive hematopoietic progenitors in myeloid metaplasia with myelofibrosis?
Blood 2003;102(4):1551-2.
2002: Pierre Champelovier; Nathalie Boucard; Geraldine Levacher; Annick Simon; Daniel Seigneurin; Vincent Praloran
Plasminogen- and colony-stimulating factor-1-associated markers in bladder carcinoma: diagnostic value of urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 using immunocytochemical analysis.
Urological research 2002;30(5):301-9.
2002: Jean-François Viallard; Anne Solanilla; Bruno Gauthier; Cécile Contin; Julie Déchanet; Christophe Grosset; Jean-François Moreau; Vincent Praloran; Paquita Nurden; Jean-Luc Pellegrin; Alan T Nurden; Jean Ripoche
Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis.
Blood 2002;99(7):2612-4.
2002: Stéphanie Frétier; Arnaud Besse; Adriana Delwail; Martine Garcia; Franck Morel; Valérie Leprivey-Lorgeot; John Wijdenes; Vincent Praloran; Jean-Claude Lecron
Cyclosporin A inhibition of macrophage colony-stimulating factor (M-CSF) production by activated human T lymphocytes.
Journal of leukocyte biology 2002;71(2):289-94.
2002: Vanessa Desplat; Jean-Luc Faucher; François-Xavier Mahon; Persio Dello Sbarba; Vincent Praloran; Zoran Ivanovic
Hypoxia modifies proliferation and differentiation of CD34(+) CML cells.
Stem cells (Dayton, Ohio) 2002;20(4):347-54.
2002: Philippe Brunet de la Grange; Zoran Ivanovic; Valérie Leprivey-Lorgeot; Vincent Praloran
Angiotensin II that reduces the colony-forming ability of hematopoietic progenitors in serum free medium has an inverse effect in serum-supplemented medium.
Stem cells (Dayton, Ohio) 2002;20(3):269-71.
2002: Zoran Ivanovic; Francis Belloc; Jean-Luc Faucher; Maria-Grazia Cipolleschi; Vincent Praloran; Persio Dello Sbarba
Hypoxia maintains and interleukin-3 reduces the pre-colony-forming cell potential of dividing CD34(+) murine bone marrow cells.
Experimental hematology 2002;30(1):67-73.
2001: Bruno François; Franck Trimoreau; Arnaud Desachy; Arnaud Besse; S Rangez; Vincent Praloran; Philippe Vignon
[Hemophagocytosis during multiple organ failure: M-CSF overproduction or viral reactivation?].
Annales françaises d'anesthèsie et de rèanimation 2001;20(6):514-9.
2001: Pierre Champelovier; Arnaud Besse; N Boucard; Annick Simon; D Leroux; N Pinel; Vincent Praloran; Daniel Seigneurin
Dag-1 carcinoma cell in studying the mechanisms of progression and therapeutic resistance in bladder cancer.
European urology 2001;39(3):343-8.
2001: Irène Dobo; Pascal Mossuz; Lydia Campos; François Girodon; A Allégraud; Véronique Latger-Cannard; Nathalie Boiret; Danielle Pineau; E Wunder; Marc Zandecki; Vincent Praloran; Sylvie Hermouet
Comparison of four serum-free, cytokine-free media for analysis of endogenous erythroid colony growth in polycythemia vera and essential thrombocythemia.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(6):396-403.
2000: Z Ivanović; Persio Dello Sbarba; Franck Trimoreau; Jean-Luc Faucher; Vincent Praloran
Primitive human HPCs are better maintained and expanded in vitro at 1 percent oxygen than at 20 percent.
Transfusion 2000;40(12):1482-8.
2000: Vanessa Desplat; Zoran Ivanovic; F Dupuis; Jean-Luc Faucher; Yves Denizot; Vincent Praloran
Effects of lipoxygenase metabolites of arachidonic acid on the growth of human blood CD34(+) progenitors.
Blood cells, molecules & diseases 2000;26(5):427-36.
2000: Vanessa Desplat; Arnaud Besse; Y Denizot; Vincent Praloran
Is the COX-2 effect on accelerated hematopoiesis mediated by prostaglandin E2?
Experimental hematology 2000;28(7):741-2.
2000: Arnaud Besse; Franck Trimoreau; Vincent Praloran; Yves Denizot
Effect of cytokines and growth factors on the macrophage colony-stimulating factor secretion by human bone marrow stromal cells.
Cytokine 2000;12(5):522-5.
2000: Yves Denizot; Sylvie Raher; Franck Trimoreau; Vincent Praloran; Anne Godard
Effect of cytokines and lipid mediators on the synthesis of interleukin 1 beta by human bone marrow stromal cells.
Cytokine 2000;12(5):499-502.
2000: Maria-Grazia Cipolleschi; Elisabetta Rovida; Zoran Ivanovic; Vincent Praloran; Massimo Olivotto; Persio Dello Sbarba
The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability.
Leukemia 2000;14(4):735-9.
2000: Vanessa Desplat; C Dulery; Jean-Luc Faucher; Vincent Praloran; Yves Denizot
Metabolism and effect of platelet-activating factor on the growth of human myeloma cell lines.
Cancer letters 2000;149(1-2):7-13.
2000: Z Ivanović; Benedetta Bartolozzi; Pietro Antonio Bernabei; Maria-Grazia Cipolleschi; Elisabetta Rovida; P Milenković; Vincent Praloran; Persio Dello Sbarba
Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors.
British journal of haematology 2000;108(2):424-9.
1999: Yann Le Meur; V Lorgeot; Jean-Claude Aldigier; J Wijdenes; Claude Leroux-Robert; Vincent Praloran
Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(10):2420-6.
1999: Yves Denizot; Pascal Turlure; Dominique Bordessoule; Franck Trimoreau; Vincent Praloran
Serum IL-10 and IL-13 concentrations in patients with haematological malignancies.
Cytokine 1999;11(8):634-5.
1999: Yves Denizot; Anne Godard; Sylvie Raher; Franck Trimoreau; Vincent Praloran
Lipid mediators modulate the synthesis of interleukin 8 by human bone marrow stromal cells.
Cytokine 1999;11(8):606-10.
1999: Arnaud Besse; Franck Trimoreau; Jean-Luc Faucher; Vincent Praloran; Yves Denizot
Prostaglandin E2 regulates macrophage colony stimulating factor secretion by human bone marrow stromal cells.
Biochimica et biophysica acta 1999;1450(3):444-51.
1999: Yves Denizot; C Dulery; Vanessa Desplat; Vincent Praloran
Incorporation and effect of arachidonic acid on the growth of the human K562 cell line.
Cancer letters 1999;139(1):75-8.
1999: Yves Denizot; Arnaud Besse; Sylvie Raher; Rachida Nachat; Franck Trimoreau; Vincent Praloran; Anne Godard
Interleukin-4 (IL-4), but not IL-10, regulates the synthesis of IL-6, IL-8 and leukemia inhibitory factor by human bone marrow stromal cells.
Biochimica et biophysica acta 1999;1449(1):83-92.
1999: Vanessa Desplat; Barbara Petit; Franck Trimoreau; Vincent Praloran; Yves Denizot
EP2 and EP4 receptor subtypes in human bone marrow stromal cells.
British journal of haematology 1999;104(2):421-2.
1999: Vanessa Desplat; C Dulery; Vincent Praloran; Yves Denizot
Incorporation and effect of arachidonic acid on the growth of human myeloma cell lines.
Mediators of inflammation 1999;8(2):115-8.
1999: Yves Denizot; Vanessa Desplat; C Dulery; Franck Trimoreau; Vincent Praloran
Arachidonic acid and freshly isolated human bone marrow mononuclear cells.
Mediators of inflammation 1999;8(1):31-5.
1999: Z Ivanović; Benedetta Bartolozzi; Pietro Antonio Bernabei; Maria-Grazia Cipolleschi; Pavle Milenkovic; Vincent Praloran; P DelloSbarba
A simple, one-step clonal assay allows the sequential detection of committed (CFU-GM-like) progenitors and several subsets of primitive (HPP-CFC) murine progenitors.
Stem cells (Dayton, Ohio) 1999;17(4):219-25.
1999: Vanessa Desplat; Arnaud Besse; Jean-Luc Faucher; Vincent Praloran; Yves Denizot
Expression of platelet-activating factor receptor transcript-1 but not transcript-2 by human bone marrow cells.
Stem cells (Dayton, Ohio) 1999;17(2):121-4.
1998: Vincent Pitard; V Lorgeot; Jean-Luc Taupin; Y Aubard; Vincent Praloran; Jean-François Moreau
The presence in human serum of a circulating soluble leukemia inhibitory factor receptor (sgp190) and its evolution during pregnancy.
European cytokine network 1998;9(4):599-605.
1998: Yves Denizot; Franck Trimoreau; Vincent Praloran
Effects of lipid mediators on the synthesis of leukaemia inhibitory factor and interleukin 6 by human bone marrow stromal cells.
Cytokine 1998;10(10):781-5.
1998: L Comte; V Lorgeot; J Bignon; L Volkov; F Dupuis; Joanna Wdzieczak-Bakala; Vincent Praloran
In vivo modifications of AcSDKP metabolism and haematopoiesis in mice treated with 5-fluorouracil and Goralatide.
European journal of clinical investigation 1998;28(10):856-63.
1998: Vincent Praloran; L Comte; Yann Le Meur; Jean-Claude Aldigier
Regulation of erythropoiesis by bone marrow reninangiotensin system: facts and speculations.
Experimental hematology 1998;26(11):1020-1.
1998: Pascal Mossuz; Irène Dobo; M C Genevay; A Allegraud; M Dautel; A E Niaussat; F Cousin; Vincent Praloran; C Boccaccio; Sylvie Hermouet
Use of collagen for standardization of PBSC graft quality evaluation: a multicenter comparative analysis of commercial collagen-based and methylcellulose-based colony-forming unit (CFU) assay kits.
Journal of hematotherapy 1998;7(4):351-9.
1998: Yves Denizot; C Dulery; Franck Trimoreau; Vanessa Desplat; Vincent Praloran
Arachidonic acid and human bone marrow stromal cells.
Biochimica et biophysica acta 1998;1402(2):209-15.
1998: Franck Trimoreau; Nathalie Gachard; Arnaud Jaccard; F Boutros Toni; Dominique Bordessoule; Vincent Praloran
B cell compartments in multiple myeloma: flow cytometric analysis of their labelling indices and Bcl-2 protein expression.
Hematology and cell therapy 1998;40(1):11-6.
1998: F Rougier; Elisabeth Cornu; Vincent Praloran; Yves Denizot
IL-6 and IL-8 production by human bone marrow stromal cells.
Cytokine 1998;10(2):93-7.
1998: Vanessa Desplat; F Dupuis; Franck Trimoreau; C Dulery; Vincent Praloran; Yves Denizot
Effects of lipoxygenase metabolites of arachidonic acid on the growth of human mononuclear marrow cells and marrow stromal cell cultures.
Mediators of inflammation 1998;7(1):31-3.
1998: F Dupuis; Nathalie Gachard; A Allegraud; C Dulery; Vincent Praloran; Yves Denizot
Effect of platelet-activating factor on the growth of human erythroid and myeloid CD34+ progenitors.
Mediators of inflammation 1998;7(2):99-103.
1998: P Fixe; Vincent Praloran
M-CSF: haematopoietic growth factor or inflammatory cytokine?
Cytokine 1998;10(1):32-7.
1997: F Dupuis; S Levasseur; Francette Jean-Louis; C Dulery; Vincent Praloran; Yves Denizot; L Michel
Production, metabolism and effect of platelet-activating factor on the growth of the human K562 erythroid cell line.
Biochimica et biophysica acta 1997;1359(3):241-9.
1997: V Lorgeot; F Rougier; P Fixe; Elisabeth Cornu; Vincent Praloran; Yves Denizot
Spontaneous and inducible production of leukaemia inhibitory factor by human bone marrow stromal cells.
Cytokine 1997;9(10):754-8.
1997: L Comte; V Lorgeot; L Volkov; A Allegraud; Jean-Claude Aldigier; Vincent Praloran
Effects of the angiotensin-converting enzyme inhibitor enalapril on blood haematopoietic progenitors and acetyl-N-Ser-Asp-Lys-Pro concentrations.
European journal of clinical investigation 1997;27(9):788-90.
1997: Bruno François; Franck Trimoreau; Philippe Vignon; P Fixe; Vincent Praloran; Hervé Gastinne
Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor.
The American journal of medicine 1997;103(2):114-20.
1997: Pierre Champelovier; P Fixe; O Valiron; Jean-Jacques Feige; Vincent Praloran; Daniel Seigneurin
Proliferation of LAMA-84 and LAMA-87 cell lines is modulated by autocrine loops involving M-CSF and TGF-beta.
Experimental hematology 1997;25(9):958-65.
1997: F Rougier; F Dupuis; Elisabeth Cornu; C Dulery; Vincent Praloran; Yves Denizot
Platelet-activating factor and antagonists modulate DNA synthesis in human bone marrow stromal cell cultures.
Journal of lipid mediators and cell signalling 1997;16(3):147-53.
1997: F Dupuis; Vanessa Desplat; Vincent Praloran; Yves Denizot
Effects of lipidic mediators on the growth of human myeloid and erythroid marrow progenitors.
Journal of lipid mediators and cell signalling 1997;16(3):117-25.
1997: P Fixe; Vincent Praloran
Macrophage colony-stimulating-factor (M-CSF or CSF-1) and its receptor: structure-function relationships.
European cytokine network 1997;8(2):125-36.
1997: Franck Trimoreau; C Verger; Vincent Praloran; Y Denizot
No sex-related difference in the myeloid:erythroid ratio in morphologically normal bone marrow aspirates.
British journal of haematology 1997;97(3):687-8.
1997: Marie-Claire Martyré; Marie-Caroline Le Bousse-Kerdiles; N Romquin; Sylvie Chevillard; Vincent Praloran; Jean-Loup Demory; Brigitte Dupriez
Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis.
British journal of haematology 1997;97(2):441-8.
1997: Yves Denizot; F Rougier; F Dupuis; Franck Trimoreau; C Dulery; M Laskar; Vincent Praloran
Presence and metabolism of lyso platelet-activating factor in human bone marrow.
Journal of lipid mediators and cell signalling 1997;16(1):53-62.
1997: P Fixe; F Rougier; E Ostyn; Nathalie Gachard; Jean-Luc Faucher; Vincent Praloran; Yves Denizot
Spontaneous and inducible production of macrophage colony-stimulating factor by human bone marrow stromal cells.
European cytokine network 1997;8(1):91-5.
1997: V Lorgeot; Franck Trimoreau; Nathalie Gachard; Vincent Praloran; Yves Denizot
Leukemia inhibitory factor concentrations in the bone marrow plasma of healthy subjects and patients with hematologic malignancies.
European cytokine network 1997;8(1):57-9.
1997: Christophe Brigaudeau; Franck Trimoreau; Nathalie Gachard; E Rouzier; Arnaud Jaccard; Dominique Bordessoule; Vincent Praloran
Cytogenetic study of 30 patients with multiple myeloma: comparison of 3 and 6 day bone marrow cultures stimulated or not with cytokines by using a miniaturized karyotypic method.
British journal of haematology 1997;96(3):594-600.
1997: F Dupuis; F Rougier; Franck Trimoreau; E Ostyn; C Dulery; Vincent Praloran; Yves Denizot
Production and metabolism of platelet-activating factor by human bone marrow cells.
Research in immunology 1997;148(2):119-26.
1997: E Liozon; Christophe Brigaudeau; Franck Trimoreau; F Desangles; V Fermeaux; Vincent Praloran; Dominique Bordessoule
Is treatment with hydroxyurea leukemogenic in patients with essential thrombocythemia? An analysis of three new cases of leukaemic transformation and review of the literature.
Hematology and cell therapy 1997;39(1):11-8.
1997: J Li; L Volkov; L Comte; P Herve; Vincent Praloran; Pierre Charbord
Production and consumption of the tetrapeptide AcSDKP, a negative regulator of hematopoietic stem cells, by hematopoietic microenvironmental cells.
Experimental hematology 1997;25(2):140-6.
1997: V Lorgeot; Vincent Praloran; Pascal Turlure; Yves Denizot
Concentrations of serum leukemia inhibitory factor (LIF) in patients with hematologic malignancies.
Leukemia 1997;11(2):311-2.
1997: L Comte; V Lorgeot; L Volkov; B Roullet; N Tubiana; Vincent Praloran
AcSDKP plasma concentrations in patients with solid tumours: comparison of two chemotherapeutic regimens.
Cancer letters 1997;112(1):1-4.
1997: F Rougier; E Cornu; N Gachard; Vincent Praloran; Yves Denizot
Tumour necrosis factor-alpha (TNFalpha) stimulates the growth of human bone marrow stromal cells.
Mediators of inflammation 1997;6(3):233-5.
1997: A Allegraud; Irène Dobo; Vincent Praloran
Collagen gel culture of the human hematopoietic progenitors CFU-GM, CFU-E, and BFU-E.
Methods in molecular biology (Clifton, N.J.) 1997;75():221-30.
1996: Yves Denizot; F Dupuis; Franck Trimoreau; C Verger; A Allegraud; Vincent Praloran
PAF and haematopoiesis: IX. Platelet-activating factor increases DNA synthesis in human bone marrow cells.
Journal of lipid mediators and cell signalling 1996;15(1):1-4.
1996: F Dupuis; C Dulery; Vincent Praloran; Yves Denizot
PAF and haematopoiesis XII: macrophage colony-stimulating factor (M-CSF) decreases platelet-activating factor (PAF) acetylhydrolase production in macrophagic J774 cells.
Cancer letters 1996;107(2):199-204.
1996: P Auguste; O Robledo; C Olivier; Josy Froger; Vincent Praloran; A Pouplard-Barthelaix; Hugues Gascan
Alanine substitution for Thr268 and Asp269 of soluble ciliary neurotrophic factor (CNTF) receptor alpha component defines a specific antagonist for the CNTF response.
The Journal of biological chemistry 1996;271(42):26049-56.
1996: Yann Le Meur; P Fixe; Jean-Claude Aldigier; Claude Leroux-Robert; Vincent Praloran
Macrophage colony stimulating factor involvement in uremic patients.
Kidney international 1996;50(3):1007-12.
1996: Yves Denizot; F Rougier; F Dupuis; C Verger; C Dulery; Marc Laskar; Jean-Claude Aldigier; Vincent Praloran
PAF and hematopoiesis. VIII. Biosynthesis and metabolism of PAF by human bone marrow stromal cells.
Experimental hematology 1996;24(11):1327-32.
1996: Christophe Brigaudeau; Nathalie Gachard; D Clay; P Fixe; E Rouzier; Vincent Praloran
A "miniaturized" method for the karyotypic analysis of bone marrow or blood samples in hematological malignancies.
Hematology and cell therapy 1996;38(3):275-7.
1996: P Fixe; V Lorgeot; Yann Le Meur; L Coupey; Dominique Heymann; Anne Godard; Vincent Praloran
Development of enzymo-immunoassays (EIA) for macrophage colony-stimulating factor (M-CSF) and leukaemia inhibitory factor (LIF) by using the same capture and signal generating polyclonal antibody.
Cytokine 1996;8(7):586-91.
1996: Dominique Heymann; E L'Her; J M NGuyen; Sylvie Raher; I Canfrère; L Coupey; P Fixe; Edmond Chailleux; DD De Groote; Vincent Praloran; Anne Godard
Leukaemia inhibitory factor (LIF) production in pleural effusions: comparison with production of IL-4, IL-8, IL-10 and macrophage-colony stimulating factor (M-CSF).
Cytokine 1996;8(5):410-6.
1996: Yves Denizot; P Fixe; Franck Trimoreau; Vincent Praloran
Macrophage colony-stimulating factor levels in the plasma of bone marrow aspirate in several hematological malignancies.
Stem cells (Dayton, Ohio) 1996;14(3):363-5.
1996: Yves Denizot; P Fixe; Eric Liozon; Vincent Praloran
Serum interleukin-8 (IL-8) and IL-6 concentrations in patients with hematologic malignancies.
Blood 1996;87(9):4016-7.
1996: O Robledo; P Auguste; L Coupey; Vincent Praloran; Sylvie Chevalier; A Pouplard; Hugues Gascan
Binding interactions of leukemia inhibitory factor and ciliary neurotrophic factor with the different subunits of their high affinity receptors.
Journal of neurochemistry 1996;66(4):1391-9.
1996: F Dupuis; Yves Denizot; P Fixe; C Dulery; Vincent Praloran
PAF and haematopoiesis. X. Macrophage colony-stimulating factor and granulocyte macrophage colony-stimulating factor enhance platelet-activating factor acetylhydrolase production by human blood-derived macrophages.
Biochimica et biophysica acta 1996;1311(1):27-32.
1996: L Volkov; P Quéré; F Coudert; L Comte; Y Antipov; Vincent Praloran
The tetrapeptide AcSDKP, a negative regulator of cell cycle entry, inhibits the proliferation of human and chicken lymphocytes.
Cellular immunology 1996;168(2):302-6.
1996: Christophe Brigaudeau; Eric Liozon; P Bernard; Franck Trimoreau; Dominique Bordessoule; Vincent Praloran
Deletion of chromosome 20q associated with hypereosinophilic syndrome. A report of two cases.
Cancer genetics and cytogenetics 1996;87(1):82-4.
1996: L Volkov; P Quéré; F Coudert; L Comte; Vincent Praloran
The tetrapeptide AcSDKP, a physiological inhibitor of normal cell proliferation, reduces the S phase entry of continuous cell lines.
Experimental cell research 1996;223(1):112-6.
1996: Yves Denizot; F Rougier; Elisabeth Cornu; Vincent Praloran
Platelet-activating factor and haematopoiesis. XI. Platelet-activating factor has no effect on the production of interleukin-6 and tumor necrosis factor-alpha by human bone marrow stromal cells.
European cytokine network 1996;7(1):75-7.
1995: Yves Denizot; Franck Trimoreau; F Dupuis; C Verger; Vincent Praloran
Platelet-activating factor concentrations in bone marrow of patients with lymphoid and nonlymphoid hematologic malignancies.
Leukemia 1995;9(11):1982-3.
1995: Irène Dobo; A Allegraud; Jean-Marc Navenot; M Boasson; J M Bidet; Vincent Praloran
Collagen matrix: an attractive alternative to agar and methylcellulose for the culture of hematopoietic progenitors in autologous transplantation products.
Journal of hematotherapy 1995;4(4):281-7.
1995: P Fixe; Yves Denizot; Eric Liozon; Dominique Bordessoule; Vincent Praloran
Serum macrophage colony-stimulating factor concentrations in patients with lymphoid and non-lymphoid hematologic malignancies.
European cytokine network 1995;6(4):217-8.
1995: Y Denizot; P Fixe; Eric Liozon; Christophe Brigaudeau; Vincent Praloran
Serum IL-6 concentrations in lymphomas.
British journal of haematology 1995;90(3):731-2.
1995: Yves Denizot; J L Charissoux; N Nathan; Vincent Praloran
PAF and haematopoiesis: V. Platelet-activating factor and acetylhydrolase in human femoral bone marrow.
Journal of lipid mediators and cell signalling 1995;12(1):45-7.
1995: Yves Denizot; F Dupuis; Franck Trimoreau; Vincent Praloran; Eric Liozon
Decreased levels of platelet-activating factor in blood of patients with lymphoid and nonlymphoid hematologic malignancies.
Blood 1995;85(10):2992-3.
1995: Eric Liozon; L Volkov; L Comte; Franck Trimoreau; P Pradelles; Dominique Bordessoule; E Frindel; Vincent Praloran
AcSDKP serum concentrations vary during chemotherapy in patients with acute myeloid leukaemia.
British journal of haematology 1995;89(4):917-20.
1995: Yves Denizot; Franck Trimoreau; F Dupuis; C Verger; Vincent Praloran
PAF and haematopoiesis: III. Presence and metabolism of platelet-activating factor in human bone marrow.
Biochimica et biophysica acta 1995;1265(1):55-60.
1995: Vincent Praloran; Yann Le Meur; L Coupey; M Rince
Increased levels of serum macrophage colony stimulating factor (M-CSF or CSF-1) in patients with chronic renal insufficiency (CRF): facts and hypotheses.
Cytokine 1995;7(2):221-2.
1995: Yves Denizot; F Dupuis; L Comte; C Dulery; Vincent Praloran
PAF and haematopoiesis. IV. Modifications of spleen and thymus PAF contents after a single dose of the chemotherapeutic drug 5-fluorouracil in mice.
Cancer letters 1995;88(2):185-9.
1995: L Volkov; L Comte; E Frindel; M Philippe; Vincent Praloran
The concentrations of AcSDKP, a physiological inhibitor of cell proliferation, vary during oogenesis and early development in Xenopus laevis.
Biology of the cell / under the auspices of the European Cell Biology Organization 1995;85(2-3):223-5.
1994: Yves Denizot; F Dupuis; B Roullet; Vincent Praloran
PAF and hematopoiesis. II. Elevated levels of plasma paf acetylhydrolase after rapid infusion of 5-fluorouracil in cancer patients.
Cancer letters 1994;85(2):185-8.
1994: Sylvie Chevalier; Vincent Praloran; C Smith; D MacGrogan; N Y Ip; G D Yancopoulos; P Brachet; A Pouplard; Hugues Gascan
Expression and functionality of the trkA proto-oncogene product/NGF receptor in undifferentiated hematopoietic cells.
Blood 1994;83(6):1479-85.
1994: Vincent Praloran; L Coupey; M Donnard; L Berrada; M F Naud
Elevation of serum M-CSF concentrations during pregnancy and ovarian hyperstimulation.
British journal of haematology 1994;86(3):675-7.
1993: L Coupey; L Berrada; Hugues Gascan; Anne Godard; Vincent Praloran
High titre anticytokine antibodies obtained by intralymphnode immunization with low amounts of antigen.
Cytokine 1993;5(6):564-9.
1993: Vincent Praloran; F Mechinaud-Lacroix
Production and role of macrophage colony stimulating factor (CSF-1 or M-CSF) in hematological pathology.
Nouvelle revue française d'hématologie 1993;35(3):227-9.
1993: Richard Garand; S Voisin; S Papin; Vincent Praloran; Bernard Lenormand; M Favre; P Philip; M Bernier; D Vanhaecke; A Falkenrodt
Characteristics of pro-T ALL subgroups: comparison with late T-ALL. The Groupe d'Etude Immunologique des Leucémies.
Leukemia 1993;7(2):161-7.
1992: F Gaillard; F Mechinaud-Lacroix; S Papin; A Moreau; C Mollat; M Fiche; S Peltier; P J De Faucal; M C Rousselet; Vincent Praloran
Primary Epstein-Barr virus infection with clonal T-cell lymphoproliferation.
American journal of clinical pathology 1992;98(3):324-33.
1992: E Claret; Vincent Praloran; X Zheng; Thierry Bonnefoix; Marie-France Sotto; J C Renversez; M P Piccinni; L Berrada; Jean-Jacques Sotto
Accumulation of T-cell clones producing high levels of both granulocyte-macrophage and macrophage colony-stimulating factors (CSF-1) in lymph nodes involved by Hodgkin's disease.
Leukemia 1992;6(8):820-7.
1992: A Moreau; Vincent Praloran; L Berrada; L Coupey; F Gaillard
Immunohistochemical detection of cells positive for colony-stimulating factor 1 in lymph nodes from reactive lymphadenitis, and Hodgkin's disease.
Leukemia 1992;6(2):126-30.
1991: Vincent Praloran; S Mirshahi; C Favard; H Moukadiri; J Plouet
[Mitogenic activity of vasculotropin for peripheral human lymphocytes].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1991;313(1):21-6.
1991: C Favard; H Moukadiri; C Dorey; Vincent Praloran; Jean Plouët
Purification and biological properties of vasculotropin, a new angiogenic cytokine.
Biology of the cell / under the auspices of the European Cell Biology Organization 1991;73(1):1-6.
1990: Vincent Praloran; V Martin-Thouvenin; L Berrada; A Moreau; Michel Lanotte
Intralymphnode injection of human monocyte macrophage colony stimulating factor (CSF-1) as a method of obtaining high titer anti-CSF-1 antibodies.
European cytokine network 1990;1(3):177-83.
1990: Vincent Praloran; H Gascan; S Papin; S Chevalier; M Trossaërt; M C Boursier
Inducible production of macrophage colony-stimulating factor (CSF-1) by malignant and normal human T cells.
Leukemia 1990;4(6):411-4.
1990: Vincent Praloran; Irène Dobo; Richard Garand; M Klausman; M F Naud; Noël Milpied; Jean-Luc Harousseau
Collagen gel cultures for detection of spared hematopoietic progenitors in Asta Z 7557 purged human marrows.
Leukemia 1990;4(4):282-6.
1990: Hugues Gascan; I Anegón; Vincent Praloran; J Naulet; Anne Godard; Jean-Paul Soulillou; Yannick Jacques
Constitutive production of human interleukin for DA cells/leukemia inhibitory factor by human tumor cell lines derived from various tissues.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(7):2592-8.
1989: Hugues Gascan; Anne Godard; C Ferenz; J Naulet; Vincent Praloran; Marie-Alix Peyrat; R Hewick; Yannick Jacques; Jean-François Moreau; Jean-Paul Soulillou
Characterization and NH2-terminal amino acid sequence of natural human interleukin for DA cells: leukemia inhibitory factor. Differentiation inhibitory activity secreted by a T lymphoma cell line.
The Journal of biological chemistry 1989;264(36):21509-15.
1989: H Vie; S Chevalier; Richard Garand; Jean-Paul Moisan; Vincent Praloran; Marie-Claire Devilder; Jean-François Moreau; Jean-Paul Soulillou
Clonal expansion of lymphocytes bearing the gamma delta T-cell receptor in a patient with large granular lymphocyte disorder.
Blood 1989;74(1):285-90.
1989: Vincent Praloran; M Klausman; M F Naud; Jean-Luc Harousseau
Blood erythroid progenitors (CFU-E and BFU-E) in acute lymphoblastic leukemias.
Blut 1989;58(2):75-8.